Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    This updates the page’s revision/version label from **v3.5.2** to **v3.5.3** in the footer, indicating a minor site maintenance change rather than a change to the underlying trial information.
    Difference
    0.0%
    Check dated 2026-04-26T13:30:22.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added revision: v3.5.2. Removed revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T04:46:55.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 added. The previous Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T08:44:57.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:15.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.1 to v3.4.2. No changes to study details, eligibility criteria, outcomes, or participating locations.
    Difference
    0.0%
    Check dated 2026-02-13T12:32:50.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:59:13.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.